美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

Obsidian Therapeutics Inc

12.24

-0.9600-7.27%

盘后：12.20-0.0400-0.33%19:32 EDT

成交量：51.72万

成交额：642.22万

市值：7.56亿

市盈率：-0.38

高：13.39

开：13.14

低：12.07

收：13.20

52周最高：49.97

52周最低：12.07

股本：6,172.72万

流通股本：5,295.45万

量比：1.88

换手率：0.98%

股息：- -

股息率：- -

每股收益(TTM):-31.8407

每股收益(LYR):-2,056.1834

净资产收益率：--

总资产收益率：--

市净率：-2.52

市盈率(LYR):-0.01

数据加载中...

总览公司新闻资讯公告

概念

no data

没有相关数据

资金流向

资金流入：

资金流出：

新闻资讯

Leerink Partners首予Obsidian Therapeutics“跑赢大盘”评级，目标价定为每股32美元

Obsidian Therapeutics提交招股说明书，涉及最多29,164,045股普通股转售

Obsidian Therapeutics宣布：晚期黑色素瘤新药Amsoki-Cel (Obx-115) 关键注册队列首例患者成功入组

美国研究综述-Ametek、Ball Corp、麦当劳

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/OBX"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OBX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OBX\",,,,,undefined,":{"symbol":"OBX","market":"US","secType":"STK","nameCN":"Obsidian Therapeutics Inc","latestPrice":12.24,"timestamp":1791489600000,"preClose":13.2,"halted":0,"volume":517206,"hourTrading":{"tag":"盘后","latestPrice":12.2,"preClose":12.24,"latestTime":"19:32 EDT","volume":5426,"amount":66423.1,"timestamp":1791502371088,"change":-0.04,"changeRate":-0.003268,"amplitude":0.003268},"delay":0,"changeRate":-0.07272727272727265,"floatShares":52954500,"shares":61727211,"eps":-31.840738,"marketStatus":"未开盘","change":-0.96,"latestTime":"10-08 16:00:00 EDT","open":13.14,"high":13.39,"low":12.07,"amount":6422203.536057,"amplitude":0.1,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-31.840738,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1791532800000},"marketStatusCode":0,"adr":0,"exchange":"NASDAQ","adjPreClose":13.2,"preHourTrading":{"tag":"盘前","latestPrice":13.2,"preClose":13.2,"latestTime":"08:11 EDT","volume":20,"amount":264,"timestamp":1791461462794,"change":0,"changeRate":0,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":12.2,"preClose":12.24,"latestTime":"19:32 EDT","volume":5426,"amount":66423.1,"timestamp":1791502371088,"change":-0.04,"changeRate":-0.003268,"amplitude":0.003268},"volumeRatio":1.879635},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OBX\",,,,,undefined,":{"symbol":"OBX","floatShares":52954500,"roa":"--","roe":"--","lyrEps":-2056.183449,"volumeRatio":1.879635,"shares":61727211,"dividePrice":0,"high":13.39,"amplitude":0.1,"preClose":13.2,"low":12.07,"week52Low":12.07,"pbRate":"-2.52","week52High":49.9699,"institutionHeld":0,"latestPrice":12.24,"eps":-31.840738,"divideRate":0,"volume":517206,"delay":0,"ttmEps":-31.840738,"open":13.14,"prevYearClose":49.9699,"prevWeekClose":13.59,"prevMonthClose":13.73,"prevQuarterClose":13.73,"fiveDayClose":13.32,"twentyDayClose":17.16},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OBX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-04","symbol":"OBX","defaultRemindTime":1785850200000,"type":"split","dateTimestamp":1785816000000,"forFactor":10000,"toFactor":7019,"ratio":1.4247043738424277}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OBX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OBX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OBX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OBX","date":"2026-10-07","current":-0.384413,"percent":0.756098,"low":-15.919767,"twenty":-11.604295,"median":-9.371112,"eighty":-8.613049,"high":-7.414063,"avg":-10.182143,"sd":1.914033,"marketCap":816637420},"quantilePoints":[{"date":"2026-08-14","current":-8.605771,"twenty":-15.155618,"median":-12.735814,"eighty":-11.727865,"marketCap":819734144},{"date":"2026-08-21","current":-9.183431,"twenty":-13.181567,"median":-9.14022,"eighty":-8.501155,"marketCap":874758582},{"date":"2026-08-28","current":-7.750652,"twenty":-12.553874,"median":-9.051525,"eighty":-8.311938,"marketCap":738280646},{"date":"2026-09-04","current":-11.204373,"twenty":-11.465176,"median":-9.062896,"eighty":-8.061315,"marketCap":1055698450},{"date":"2026-09-11","current":-11.250266,"twenty":-12.259905,"median":-9.14022,"eighty":-8.254627,"marketCap":1060022552},{"date":"2026-09-18","current":-11.473173,"twenty":-12.018641,"median":-11.145368,"eighty":-8.451122,"marketCap":1081025330},{"date":"2026-09-25","current":-8.791729,"twenty":-11.748529,"median":-11.145368,"eighty":-8.565744,"marketCap":828374267},{"date":"2026-10-02","current":-8.732724,"twenty":-11.650188,"median":-10.004607,"eighty":-8.565744,"marketCap":822814708},{"date":"2026-10-07","current":-8.667163,"twenty":-11.604295,"median":-9.371112,"eighty":-8.613049,"marketCap":816637420}],"updateTime":1791508609004},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OBX\",pageSize:4,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1118547263","title":"Leerink Partners首予Obsidian Therapeutics“跑赢大盘”评级，目标价定为每股32美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1118547263","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118547263?lang=zh_cn&edition=fundamental","pubTime":"2026-09-22 18:09","pubTimestamp":1790071749,"startTime":"0","endTime":"0","summary":"Leerink Partners近日正式启动对Obsidian Therapeutics Inc（简称Obsidian Therapeutics）的覆盖研究，并给出“跑赢大盘”的初始评级。与此同时，该机构将这家公司的目标股价设定为每股32美元。此举标志着投行对这家生物科技领域新兴力量的关注度正显著提升。值得注意的是，Leerink Partners的这份评级报告，为投资者提供了关于Obsidian Therapeutics未来发展潜力的全新视角。在当下竞争激烈的市场环境中，这一目标价显然反映出机构对其前景抱有一定程度的乐观预期。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180960798","title":"Obsidian Therapeutics提交招股说明书，涉及最多29,164,045股普通股转售","url":"https://stock-news.laohu8.com/highlight/detail?id=1180960798","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1180960798?lang=zh_cn&edition=fundamental","pubTime":"2026-08-29 05:13","pubTimestamp":1787951593,"startTime":"0","endTime":"0","summary":"Obsidian Therapeutics Inc已向美国证券交易委员会提交了一份招股说明书，内容涉及出售股东转售最多29,164,045股普通股。此次提交的招股说明书并未涉及公司自身的资金募集行为，而是旨在为股东提供一个合规的转售平台。值得关注的是，Obsidian Therapeutics专注于细胞疗法的开发，其核心研发管线正处於临床前及早期临床阶段。此类公司的股价对融资及股东活动尤为敏感，本次提交的招股书亦将成为投资者近期评估该公司股票供需关系的关键参考。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OBX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1160444967","title":"Obsidian Therapeutics宣布：晚期黑色素瘤新药Amsoki-Cel (Obx-115) 关键注册队列首例患者成功入组","url":"https://stock-news.laohu8.com/highlight/detail?id=1160444967","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1160444967?lang=zh_cn&edition=fundamental","pubTime":"2026-08-05 19:06","pubTimestamp":1785927982,"startTime":"0","endTime":"0","summary":"Obsidian Therapeutics公司今日重磅宣布，其针对晚期黑色素瘤的细胞疗法——Amsoki-Cel（原名Obx-115），在1/2期Agni-01研究的注册导向队列中，已成功完成首例患者入组。这一里程碑事件，标志着该创新疗法正式迈入关键性临床开发阶段，为全球黑色素瘤患者带来了全新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OBX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657519496","title":"美国研究综述-Ametek、Ball Corp、麦当劳","url":"https://stock-news.laohu8.com/highlight/detail?id=2657519496","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657519496?lang=zh_cn&edition=fundamental","pubTime":"2026-08-05 15:57","pubTimestamp":1785916639,"startTime":"0","endTime":"0","summary":"美国研究综述-Ametek、Ball Corp、麦当劳路透8月5日-周三，华尔街证券分析师下调了多家在美国上市公司的评级和目标股价，其中包括阿美特克、鲍尔公司和麦当劳。要点* 阿美特克AME.N：加拿大皇家银行将目标价从260美元上调至291美元* 博尔公司BALL.N：摩根大通将评级从“增持”下调至“中性”* 麦当劳MCD.N：摩根大通将目标价从305美元下调至280美元以下是路透周三报道的针对美国公司的研究报告摘要。股票按字母顺序排列。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260805:nL4S4420OI:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PINS","TVTX","JXN","PRCT","TPG","MCD","ANET","CMI","TOST","OPLN","BBY","HSIC","PLTR","W","BALL","PPLI","ALAB","CAT","MKL","WAT","BKNG","ZBRA","EMR","FBIN","GILD","AME","LMAT","AMD","HLNE","KTOS","NPO","YETI","BDX","ARWR","CINF","QLYS","SYY","PCTY","IT","BR","BRKR","HNGE","OBX","LSCC","AMGN","XMTR","MRK","SPCX","BL"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":2,"pageCount":1,"totalSize":5,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/OBX\",params:#limit:6,delay:false,,,undefined,":[]}}